APA (7th ed.) Citation

Ramessur, A., Harper-Wyne, C., Burcombe, R., & Jyothirmayi, R. (2017). The Use of Oncotype DX in Adjuvant Chemotherapy Decision-making in Early Breast Cancer Patients with Intermediate Risk of Mortality at 10 Years. Clinical Oncology, 29(6), e103. https://doi.org/10.1016/j.clon.2017.01.032

Chicago Style (17th ed.) Citation

Ramessur, A., C. Harper-Wyne, R. Burcombe, and R. Jyothirmayi. "The Use of Oncotype DX in Adjuvant Chemotherapy Decision-making in Early Breast Cancer Patients with Intermediate Risk of Mortality at 10 Years." Clinical Oncology 29, no. 6 (2017): e103. https://doi.org/10.1016/j.clon.2017.01.032.

MLA (9th ed.) Citation

Ramessur, A., et al. "The Use of Oncotype DX in Adjuvant Chemotherapy Decision-making in Early Breast Cancer Patients with Intermediate Risk of Mortality at 10 Years." Clinical Oncology, vol. 29, no. 6, 2017, p. e103, https://doi.org/10.1016/j.clon.2017.01.032.